Pulmonx Corporation ( LUNG) - Key Metrics
LUNG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.55 | -$0.25 | ? | ? |
| 2025Q3 | $0.53 | -$0.34 | -$0.20 | -$0.20 |
| 2025Q2 | $0.59 | -$0.38 | -$0.10 | -$0.10 |
| 2025Q1 | $0.56 | -$0.36 | -$0.33 | -$0.34 |
LUNG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.19 |
| 2025Q3 | ? | -1.19 |
| 2025Q2 | ? | -1.72 |
| 2025Q1 | ? | -4.65 |
LUNG
Price: $1.28
52 week price:
Earnings Per Share: -1.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 23949
Market Capitalization: 68.4 million